Published in Adv Mater on February 23, 2010
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Refilling drug delivery depots through the blood. Proc Natl Acad Sci U S A (2014) 2.10
Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv (2012) 1.22
In vivo assembly of nanoparticle components to improve targeted cancer imaging. Proc Natl Acad Sci U S A (2010) 1.15
Plasmon-enhanced optical sensors: a review. Analyst (2015) 1.15
Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano (2011) 1.13
Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy. Nano Today (2012) 1.05
Nanoinformatics: a new area of research in nanomedicine. Int J Nanomedicine (2012) 1.03
Near-infrared light modulated photothermal effect increases vascular perfusion and enhances polymeric drug delivery. J Control Release (2011) 0.98
Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors. Theranostics (2012) 0.97
Upconverting organic dye doped core-shell nano-composites for dual-modality NIR imaging and photo-thermal therapy. Theranostics (2013) 0.97
On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles. Nat Med (2014) 0.95
Co9 se8 nanoplates as a new theranostic platform for photoacoustic/magnetic resonance dual-modal-imaging-guided chemo-photothermal combination therapy. Adv Mater (2015) 0.95
Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy. Proc Natl Acad Sci U S A (2014) 0.94
Biological stimuli and biomolecules in the assembly and manipulation of nanoscale polymeric particles. Chem Sci (2012) 0.93
Advance in photosensitizers and light delivery for photodynamic therapy. Clin Endosc (2013) 0.91
Multifunctional surface modification of gold-stabilized nanoparticles by bioorthogonal reactions. J Am Chem Soc (2011) 0.90
NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy. Sci Rep (2015) 0.89
Multi-functional self-fluorescent unimolecular micelles for tumor-targeted drug delivery and bioimaging. Biomaterials (2015) 0.89
Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolution. Anal Chem (2012) 0.88
Inorganic nanosystems for therapeutic delivery: status and prospects. Adv Drug Deliv Rev (2012) 0.85
Fluorescence imaging enabled biodegradable photostable polymeric micelles. Adv Healthc Mater (2013) 0.84
Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. J Control Release (2012) 0.84
Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy. Pharm Res (2014) 0.82
Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog (2014) 0.81
Enhancing targeted tumor treatment by near IR light-activatable photodynamic-photothermal synergistic therapy. Mol Pharm (2014) 0.79
Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology. Trends Biotechnol (2014) 0.78
Endothelial Thermotolerance Impairs Nanoparticle Transport in Tumors. Cancer Res (2015) 0.78
Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh) (2016) 0.77
The Combination of Laser Therapy and Metal Nanoparticles in Cancer Treatment Originated From Epithelial Tissues: A Literature Review. J Lasers Med Sci (2016) 0.75
Phototriggered Drug Delivery Using Inorganic Nanomaterials. Bioconjug Chem (2016) 0.75
Cancer cell death induced by nanomagnetolectin. Eur J Cell Biol (2017) 0.75
Improved Margins Detection of Regions Enriched with Gold Nanoparticles inside Biological Phantom. Materials (Basel) (2017) 0.75
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
A clearer vision for in vivo imaging. Nat Biotechnol (2001) 10.49
Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B (2006) 7.53
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol (2007) 7.33
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol (2005) 5.19
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev (2006) 4.52
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res (2006) 4.43
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release (2006) 3.74
In vitro and in vivo two-photon luminescence imaging of single gold nanorods. Proc Natl Acad Sci U S A (2005) 3.66
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett (2008) 3.20
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res (2000) 2.99
Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett (2009) 2.82
Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc (2008) 2.56
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res (2000) 2.17
Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst (2007) 2.00
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Hyperthermia and liposomes. Int J Hyperthermia (1999) 1.39
Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat Mater (2008) 1.36
Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett (2008) 1.34
Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32
Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res (1994) 1.08
Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release. Nanotechnology (2009) 1.04
Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm Res (1995) 1.00
Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. Br J Cancer (1986) 0.98
Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro. Cancer Res (1983) 0.89
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science (2010) 6.01
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A (2011) 4.15
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Targeting of drugs and nanoparticles to tumors. J Cell Biol (2010) 4.07
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res (2009) 3.77
Micromechanical control of cell-cell interactions. Proc Natl Acad Sci U S A (2007) 3.53
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev (2008) 3.43
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Probing the role of multicellular organization in three-dimensional microenvironments. Nat Methods (2006) 3.20
Three-dimensional structures self-assembled from DNA bricks. Science (2012) 3.14
Biomolecular screening with encoded porous-silicon photonic crystals. Nat Mater (2002) 3.13
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell (2004) 3.09
Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J (2006) 2.95
A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med (2002) 2.77
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol (2003) 2.68
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2003) 2.56
Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy. J Am Chem Soc (2005) 2.56
Continuous-flow lithography for high-throughput microparticle synthesis. Nat Mater (2006) 2.49
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A (2010) 2.44
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A (2009) 2.41
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci U S A (2002) 2.35
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A (2012) 2.13
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res (2008) 2.13
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol (2010) 2.05
Humanized mice with ectopic artificial liver tissues. Proc Natl Acad Sci U S A (2011) 2.03
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol (2010) 1.99
Cancer vulnerabilities unveiled by genomic loss. Cell (2012) 1.95
A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe (2013) 1.95
Delivery of nanogram payloads using magnetic porous silicon microcarriers. Lab Chip (2006) 1.93
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine (2008) 1.90
Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones. Nat Mater (2004) 1.89
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A (2004) 1.82
Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir (2004) 1.81
SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. Adv Mater (2009) 1.79
Microfabricated platform for studying stem cell fates. Biotechnol Bioeng (2004) 1.77
Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev (2008) 1.76
Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A (2009) 1.76
Three-dimensional tissue fabrication. Adv Drug Deliv Rev (2004) 1.76
A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell (2004) 1.73
Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science (2003) 1.72
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A (2011) 1.68
Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano (2011) 1.61
Stop-flow lithography in a microfluidic device. Lab Chip (2007) 1.59
Identification and characterization of receptor-specific peptides for siRNA delivery. ACS Nano (2012) 1.58
Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng (2003) 1.58
Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng (2003) 1.58
Stop-flow lithography to generate cell-laden microgel particles. Lab Chip (2008) 1.57
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell (2012) 1.56
Single cell trapping and DNA damage analysis using microwell arrays. Proc Natl Acad Sci U S A (2010) 1.53
R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat Med (2005) 1.51
Engineering protein and cell adhesivity using PEO-terminated triblock polymers. J Biomed Mater Res (2002) 1.50
Identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat Chem Biol (2013) 1.49